(AEAGX) Agenix sells AGX 1009 for $USD 2 Million to Cinkate

HD
WC
PD
SN
SC
LA
CY
LP

TD

(AEAGX) Agenix sells AGX 1009 for $USD 2 Million to Cinkate

223 words
19 May 2014
Ralph Wragg Australian Business News
AAPRAW
English
Copyright 2014 RWE AUSTRALIAN BUSINESS NEWS PTY LTD. All Rights Reserved.

Sydney - Monday - May 19 (RWE) - Agenix Limited (ASX: AGX) advises that it has reached a binding
Definitive Agreement for the sale of its AGX-1009 China project to Cinkate Pharmaceutical
Intermediates Co Ltd, for USD $2.0 million.
Under the terms of the sale, Cinkate will take over development of AGX-1009, a tenofovir prodrug for
HBV patented in China.

Four three-party cooperation agreements were also signed by Cinkate, Agenix and its Chinese
development partners the Institute of Medicinal Biotechnology, the Institute of Pharmacology and
Toxicology of the Academy of Military Medical Sciences, the Institute of Radiation Medicine of the
Academy of Military Medical Sciences, and HongHui Meditech.
Agenix chairman and chief executive Nick Weston said "The sale of AGX-1009 demonstrates our focus
on strengthening our balance sheet and exiting all operations in China".
The sale is subject to the usual conditions in respect of transactions of this nature.

The transaction is expected to settle in the second half of 2014.

For more information please contact: Nicholas Weston Tel: +61 3 8616 0379 About Agenix Agenix listed
on the Australian Securities Exchange in 1987.
Today, Agenix's lead product candidate is ThromboView, a novel radio-labelled monoclonal antibody
imaging modality for pulmonary embolism (PE) and deep vein thrombosis (DVT).

CO
IN

NS
RE

PUB
AN

btchi : Agenix Ltd
i257 : Pharmaceuticals | i951 : Health Care/Life Sciences | i372 : Medical Equipment/Supplies | iphmed :
Medical/Surgical Instruments/Apparatus/Devices
ccat : Corporate/Industrial News
austr : Australia | china : China | apacz : Asia Pacific | asiaz : Asia | ausnz : Australia/Oceania | bric :
BRIC Countries | chinaz : Greater China | devgcoz : Emerging Market Countries | dvpcoz : Developing
Economies | easiaz : Eastern Asia
RWE Australian Business News Pty Ltd
Document AAPRAW0020140518ea5j000me

Page220of269Â©2018Factiva,Inc.Allrightsreserved.